Safety of regadenoson with theophylline reversal during dynamic computed tomography perfusion and magnetic resonance imaging in patients with CAD.

CONCLUSIONS: Regadenoson may be a safe vasodilator for CTP and MR MPI in CAD patients. Theophylline administration after perfusion examinations is safe and reverses regadenoson side effects.
PMID: 32395975 [PubMed - as supplied by publisher]

Source: Polish Heart Journal - May 11, 2020 Category: Cardiology Authors: Oleksiak A, Kruk M, Śpiewak M, Miłosz-Wieczorek B, Marczak M, Demkow M, Kępka C Tags: Kardiol Pol Source Type: research